Hologic, Inc. (HOLX)

68,37 -0,85 (-1,23 %) À la clôture : 04:00PM EST

Hologic, Inc.

250 Campus Drive
Marlborough, MA 01752
United States
508 263 2900
https://www.hologic.com

Secteur(s): Healthcare
Secteur d’activité: Medical Instruments & Supplies
Employés à temps plein: 6 990

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Mr. Stephen P. MacMillan	Chairman, CEO & President	4,24M	S.O.	1964
Ms. Karleen M. Oberton	Chief Financial Officer	1,58M	S.O.	1971
Mr. John M. Griffin	General Counsel	1,47M	S.O.	1961
Mr. Jan Verstreken	Group President of International	1,24M	S.O.	1968
Mr. Paul Malenchini	Chief Information Officer	S.O.	S.O.	S.O.
Ryan M. Simon	Vice President of Investor Relations	S.O.	S.O.	S.O.
Mr. Peter Dunne	Senior Vice President of Human Resources	S.O.	S.O.	S.O.
Ms. Monica Aguirre Berthelot	VP & Chief of Staff	S.O.	S.O.	S.O.
Mr. Erik Anderson	Division President of Breast & Skeletal Health Solutions	S.O.	S.O.	1982
Mr. Essex Mitchell	Division President of GYN Surgical Solutions	S.O.	S.O.	1980

Les montants ont été établis en date du 31 décembre 2022 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Hologic, Inc. en date du 1 décembre 2023 est 8. Les scores principaux sont Audit : 8; Société : 7; Droits des actionnaires : 7; Compensation : 6.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.